Fabtech Technologies Limited is a global provider of turnkey engineering solutions for the pharmaceutical, biotech, and healthcare industries, headquartered in India. Leveraging over 29 years of operating history through its group lineage, the company specializes in delivering comprehensive, start-to-finish services for establishing aseptic manufacturing facilities, particularly greenfield projects.

The company’s core offering spans the entire project lifecycle, encompassing everything from disease identification and detailed design to engineering, procurement, installation, and certification. Their expertise addresses the three critical elements of manufacturing facilities: bio clean air, clean water, and process solutions. Fabtech maintains a significant global footprint, having executed projects in over 62 countries, with a strategic focus on key emerging economies across the Middle East, Africa, and Asia. Operating with an asset-light approach and backed by a strong order book (aggregating ₹90,441.87 lakhs as of July 31, 2025), the company is well-positioned to capitalize on the increasing global demand for resilient healthcare infrastructure, especially post-pandemic.

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

(There are no listed peers of the company in India.)

*Market cap @upper band

• Turnkey Solutions and Project Scope: A key provider of end-to-end turnkey engineering solutions in pharmaceuticals, covering design, procurement, and installation across all dosage forms.
• Asset-Light, Integrated Model: Utilizes an asset-light strategy sourcing equipment from related entities and third parties, enabling scalability, cost efficiency, and reduced capital investment.
• Global Execution & Order Book: Proven track record of project execution in diverse, challenging geographies, backed by a consistently growing, diversified order book across verticals.
• Experienced Leadership & Tech: Led by a highly experienced management team with Fabtech Group lineage, supported by the proprietary digital management tool FabAssure.

The Company FABTECH TECHNOLOGIES LIMITED IPO proposes to utilise the Net Proceeds from the Issue towards the objects:

At the upper band of IPO ₹ 191, the stock is valued at 18.28 P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.